Usana Health Sciences (USNA) Gains from Investment Securities (2016 - 2026)
Usana Health Sciences has reported Gains from Investment Securities over the past 16 years, most recently at $214000.0 for Q2 2026.
- Quarterly Gains from Investment Securities fell 90.12% to $214000.0 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $394000.0 through Apr 2026, down 83.24% year-over-year, with the annual reading at $2.3 million for FY2026, 27.18% down from the prior year.
- Gains from Investment Securities was $214000.0 for Q2 2026 at Usana Health Sciences, down from $2.5 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $4.2 million in Q2 2022 and troughed at -$4.7 million in Q4 2022.
- The 5-year median for Gains from Investment Securities is $214000.0 (2026), against an average of $732647.1.
- The largest YoY upside for Gains from Investment Securities was 9059.57% in 2022 against a maximum downside of 226.26% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at -$4.7 million in 2022, then surged by 102.85% to $134000.0 in 2023, then plummeted by 44.78% to $74000.0 in 2024, then plummeted by 228.38% to -$95000.0 in 2025, then surged by 325.26% to $214000.0 in 2026.
- Per Business Quant, the three most recent readings for USNA's Gains from Investment Securities are $214000.0 (Q2 2026), $2.5 million (Q1 2026), and -$95000.0 (Q3 2025).